- QMRO Home
- Barts Cancer Institute
- Centre for Experimental Cancer Medicine
- Cost-effectiveness of systematic population based screening for BRCA1, BRCA2, RAD51C, RAD51D and BRIP1 gene mutations in unselected general population women
Browse
Administrators only